Grimaud Brett A. sold TBPH
November 20, 2025 · Form 4 insider transaction
Grimaud Brett A. sold 19,024 shares of Theravance Biopharma, Inc. at $17.90 per share, a transaction worth $340.5K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
19,024
Price
$17.90
Total value
$340.5K
InsiderGrimaud Brett A.
RoleOfficer
SecurityOrdinary Shares
Transaction codeF: Shares withheld for taxes
Transaction dateNovember 20, 2025
Filing dateNovember 24, 2025
Shares owned after355,282
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.